<SEC-HEADER>0000899243-23-014883.hdr.sgml : 20230608
<ACCEPTANCE-DATETIME>20230608163706
<ACCESSION-NUMBER>0000899243-23-014883
<TYPE>4
<PUBLIC-DOCUMENT-COUNT>1
<PERIOD>20230607
<FILING-DATE>20230608
<DATE-OF-FILING-DATE-CHANGE>20230608
<REPORTING-OWNER>
<OWNER-DATA>
<CONFORMED-NAME>Harwin Peter Evan
<CIK>0001663607
</OWNER-DATA>
<FILING-VALUES>
<FORM-TYPE>4
<ACT>34
<FILE-NUMBER>001-38443
<FILM-NUMBER>231002465
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1>2001 MARKET STREET
<STREET2>SUITE 2500
<CITY>PHILADELPHIA
<STATE>PA
<ZIP>19103
</MAIL-ADDRESS>
</REPORTING-OWNER>
<ISSUER>
<COMPANY-DATA>
<CONFORMED-NAME>Cogent Biosciences, Inc.
<CIK>0001622229
<ASSIGNED-SIC>2834
<IRS-NUMBER>465308248
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<BUSINESS-ADDRESS>
<STREET1>275 WYMAN STREET
<STREET2>3RD FLOOR
<CITY>WALTHAM
<STATE>MA
<ZIP>02451
<PHONE>617-945-5576
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>275 WYMAN STREET
<STREET2>3RD FLOOR
<CITY>WALTHAM
<STATE>MA
<ZIP>02451
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Unum Therapeutics Inc.
<DATE-CHANGED>20180402
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>Unum Therapeutics, Inc.
<DATE-CHANGED>20141014
</FORMER-COMPANY>
</ISSUER>
</SEC-HEADER>
